Abstracts tagged "Anakinra and gout"

Abstract Number: 1291 • 2018 ACR/ARHP Annual Meeting
Efficacy and Safety of Anakinra in Congestive Heart Failure Patients, Including Lvad, with Acute Gouty Arthritis: A Retrospective Study of 36 Patients at an Academic Medical Center
Arash Hassantoufighi¹, Paloma Alejandro², Christopher E. Collins², Florina Constantinescu² and Juhi Bhargava³, ¹Rheumatology, MedStar Washington Hospital Center/Georgetown University Medical Center, washington, DC, ²Rheumatology, MedStar Washington Hospital Center/Georgetown University Medical Center, Washington, DC, ³Internal Medicine, MedStar Washington Hospital Center/Georgetown University Medical Center, washington, DC
Background/Purpose: Gout is the most common inflammatory arthritis worldwide and many patients with gout are ‘complicated’ by multiple comorbidities including metabolic syndrome, renal disease and…
Abstract Number: 1142 • 2017 ACR/ARHP Annual Meeting
A Case Control Study of Anakinra Use for Acute Gout in a VA Patient Cohort Reveals Association with East Asian Descent, High Urate Burden, and Increased Co-Morbidities and All-Cause Mortality
Ena Sharma¹ and Robert Terkeltaub², ¹Rheumatology, University Of California San Diego, San Diego, CA, ²Rheumatology, VA San Diego Healthcare System, San Diego, CA
Background/Purpose: Effectiveness of the IL-1 receptor antagonist anakinra, in resolving flares of acute gout, has been reported in several case series. Here, studying a VA…
Abstract Number: 146 • 2012 ACR/ARHP Annual Meeting
The Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients with Anakinra
Mary Bach¹, Jane Park¹, Pradipta Ghosh¹, Peter A. Simkin² and Gregory C. Gardner³, ¹Rheumatology, University of Washington, Seattle, WA, ²Div of Rheumatology, University of Washington, Seattle, WA, ³Medicine/Rheumatology, University of Washington, Seattle, WA
Background/Purpose: The management of acute crystal-induced arthritis in the hospital setting may be a difficult clinical problem due to co-morbidities that limit the use of…